Drugs / BMS-767778
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00707590 | Aug → Nov 2008 | type 2 diabetes mellitus | Bristol-Myers Squibb | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BMS-767778 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00707590 ↗ |
| Route | Oral | “administered as single and multiple oral doses” NCT00707590 ↗ |